(R)-2-(2,3-Dihydro-1H-inden-2-yl)-1-(4-(pyrrolidine-1-carbonyl)thiazolidin-3-yl)ethan-1-one

Catalog No. :
ACMAXC098
CAS No. :
130849-58-0
Molecular Formula :
C19H24N2O2S
Molecular Weight :
344.48

IUPAC Name:(R)-2-(2,3-dihydro-1H-inden-2-yl)-1-(4-(pyrrolidine-1-carbonyl)thiazolidin-3-yl)ethan-1-one

(R)-2-(2,3-Dihydro-1H-inden-2-yl)-1-(4-(pyrrolidine-1-carbonyl)thiazolidin-3-yl)ethan-1-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg99%$391.00Login to see priceInquiryInquiry
5mg99%$900.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-2-(2,3-Dihydro-1H-inden-2-yl)-1-(4-(pyrrolidine-1-carbonyl)thiazolidin-3-yl)ethan-1-one
IUPAC Name(R)-2-(2,3-dihydro-1H-inden-2-yl)-1-(4-(pyrrolidine-1-carbonyl)thiazolidin-3-yl)ethan-1-one
Molecular FormulaC19H24N2O2S
Molecular Weight344.48
SMILESO=C(N1CCCC1)[C@@H]2CSCN2C(CC3CC4=CC=CC=C4C3)=O
InChI KeyGDOVFSONSLOIAK-KRWDZBQOSA-N
SynonymZ-321 | (4R)-3-(2-Indanacetyl)-4-(1-pyrrolidinecarbonyl)thiazolidine | M2V0Y789FK | UNII-M2V0Y789FK | Thiazolidine, 3-((2,3-dihydro-1H-inden-2-yl)acetyl)-4-(1-pyrrolidinylcarbonyl)-, (4R)- | GDOVFSONSLOIAK-KRWDZBQOSA-N | BDBM50038884 | AKOS040742839 | HY-
CAS No.130849-58-0
PubChem CID9798234

Synthetic Route by SureRoute

1. ACMAXC098 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNSQG735 route compound structure diagram
    ACNSQG73537868-26-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMAXC098 route product structure diagram
    ACMAXC098130849-58-0
Inquiry

2. ACMAXC098 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMAXC098 route product structure diagram
    ACMAXC098130849-58-0
Inquiry

Comments (0)